1.
Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-...
by Gupta, Ajay, MRCP
The Lancet (British edition), 2017, Vol.389 (10088), p.2473-2481
2.
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis...
by Bakris, George L, Dr, Prof
The Lancet (British edition), 2010, Vol.375 (9721), p.1173-1181
3.
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Car...
by Sever, Peter S
The Lancet (British edition), 2003, Vol.361 (9364), p.1149-1158
4.
Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension
by Chapman, Neil
Hypertension (Dallas, Tex. 1979), 2007-04, Vol.49 (4), p.839-845
5.
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Ang...
by Dahlöf, Björn
The Lancet (British edition), 2005-09-10, Vol.366 (9489), p.895-906
6.
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
by Dahlöf, Björn
The Lancet (British edition), 2002-03-23, Vol.359 (9311), p.995-1003
7.
Direct Angiotensin II Type 2 Receptor Stimulation Acts Anti-Inflammatory Through Epoxyeicosatrienoic Acid and Inhibition of Nuclear Factor κB
by Rompe, Franziska
Hypertension (Dallas, Tex. 1979), 2010-04, Vol.55 (4), p.924-931
8.
Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study
by Mochizuki, Seibu, Prof
The Lancet (British edition), 2007, Vol.369 (9571), p.1431-1439
9.
Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment: Losartan Intervention for Endpoint Reduction in Hypertension Trial
by Gerdts, Eva
Hypertension (Dallas, Tex. 1979), 2007-02, Vol.49 (2), p.311-316
10.
Regression of ECG-LVH is Associated with Lower Risk of New-Onset Heart Failure and Mortality in Patients with Isolated Systolic Hypertension; The LIFE Study
by LARSTORP, Anne Cecilie K
American journal of hypertension, 2012, Vol.25 (10), p.1101-1109
11.
Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study
by Ibsen, Hans
Hypertension (Dallas, Tex. 1979), 2005-02, Vol.45 (2), p.198-202
12.
Association of Pulse Pressure With New-Onset Atrial Fibrillation in Patients With Hypertension and Left Ventricular Hypertrophy: The Losartan Intervention For Endpoint (LIFE) Reduc...
by Larstorp, Anne Cecilie K
Hypertension (Dallas, Tex. 1979), 2012-08, Vol.60 (2), p.347-353
13.
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
by Rothwell, Peter M, Prof
The Lancet (British edition), 2010, Vol.375 (9718), p.895-905
14.
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenol...
by Lindholm, Lars H
The Lancet (British edition), 2002-03-23, Vol.359 (9311), p.1004-1010
15.
Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-...
by Poulter, Neil R
The Lancet (British edition), 2005-09-10, Vol.366 (9489), p.907-913
16.
Effect of Changing Heart Rate During Treatment of Hypertension on Incidence of Heart Failure
by Okin, Peter M., MD
The American journal of cardiology, 2012, Vol.109 (5), p.699-704
17.
Prognostic Significance of Left Ventricular Diastolic Dysfunction in Patients With Left Ventricular Hypertrophy and Systemic Hypertension (the LIFE Study)
by Wachtell, Kristian, MD, PhD
The American journal of cardiology, 2010, Vol.106 (7), p.999-1005
18.
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
by Hansson, Lennart
The Lancet (British edition), 1999, Vol.354 (9192), p.1751-1756
19.
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
by Hansson, Lennart
The Lancet (British edition), 1998, Vol.351 (9118), p.1755-1762
20.
Mitral Annular Calcification and Incident Ischemic Stroke in Treated Hypertensive Patients: The LIFE study
by De Marco, Marina
American journal of hypertension, 2013-04, Vol.26 (4), p.567-573
